Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Reveal Pharmaceuticals has raised $500K in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Reveal Pharmaceuticals's investors include MassChallenge, Massachusetts Life Sciences Center, MassVentures, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases.
Reveal Pharmaceuticals is headquartered in Cambridge, United States.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Reveal Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reveal Pharmaceuticals — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/reveal-pharmaceuticals. Accessed September 15, 2026.
VCBacked. (2023). Reveal Pharmaceuticals — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/reveal-pharmaceuticals
{{cite web |title=Reveal Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/reveal-pharmaceuticals |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated